Paul MacLean, PhD
Dr. Paul MacLean Ph.D. is a tenured Professor at the University of Colorado School of Medicine with 25years of experience studying obesity and its metabolic complications. He has specific interests in the biological drivers of weight regain after weight loss, exercise as a strategy for weight loss maintenance, and understanding how obesity affects key aspects of women’s health. Dr. MacLean's research in women’s health has included studies of mammary gland development and its function during lactation, perinatal metabolic programming, the menopausal transition, and the risk for breast cancer. He is dedicated to building and supporting the broader research and educational enterprise on the CU Anschutz Medical Campus through the Colorado Nutrition Obesity Research Center, the Colorado Clinical Translational Science Institute, and the University of Colorado Cancer Center. Over the past 17years at the University of Colorado, Dr. MacLean has leveraged their resources to develop the next generation of scientists who will advance the treatment of obesity and its complications.
Dan Bessesen, MD
Associate Director, NORC
Dr. Daniel Bessesen M.D. is a professor of medicine of endocrinology, metabolism, and diabetes at The University of Colorado. Dr. Bessesen received his MD with honors from The University of Colorado. He completed residency and fellowship training at The University of Colorado and has been on the faculty since 1991. He is the director of the obesity medicine fellowship program and the associate director of fellowship training in endocrinology. Dr. Bessesen is the associate director of the NIH-funded Nutrition Obesity Research Center and oversees the pilot and feasibility program. He is currently the Director of the Anschutz Health and Wellness Center on the campus of the University of Colorado, School of Medicine, an 80,000 sq. foot building with a fitness facility, a metabolic kitchen, a demonstration kitchen and a clinic. The center provides support for research, education and clinical programs in nutrition, physical activity and mental wellbeing. Dr. Bessesen has been a member of The Obesity Society since he was a post-doctoral fellow and is currently the president of TOS. Dr. Bessesen has published more than 90 scientific articles and book chapters and is the coauthor of three books, including Treatment of the Obese Patient published in 2014.
Wendy Kohrt, PhD
Director, Energy Balance Assessment Core
Dr. Wendy Kohrt Ph.D. is a Professor of Medicine in the Division of Geriatric Medicine at the University of Colorado Anschutz Medical Campus and the Nancy Anschutz Endowed Chair In Women's Health Research. She is the Director of Research for Geriatric Medicine and the Director of the IMAGE research group (Investigations in Metabolism, Aging, Gender, and Exercise). Dr. Kohrt is the Director of the Energy Balance Core Laboratory for the NIH-supported Nutrition and Obesity Research Center and is the Chair of the Scientific Advisory and Review Committee for the Adult Clinical and Translational Research Center. She served on the Federal Advisory Committee that prepared the evidence report for the first Physical Activity Guidelines for Americans, which were launched by the Department of Health and Human Services in October 2008. She is an invited member of the Isis Network on Musculoskeletal Health through the Society for Women’s Health Research. Dr. Kohrt is currently serving as co-chair of the Steering Committee assembled by the National Research Council to conduct the Decadal Survey on Biological and Physical Sciences in Space, which will recommend research to support space exploration in the 2010 to 2020 decade. Dr. Kohrt has been recognized as a Distinguished Alumnus by the University of Wisconsin Stevens Point and received a Citation Award from the American College of Sports Medicine.Dr. Kohrt has been continuously funded by the NIH as a Principal Investigator for more than two decades and has more than 140 original and solicited research publications. She is currently the Principal Investigator for two NIH R01 research awards and a Co-investigator for six other NIH awards. She has mentored or co-mentored 24 Ph.D.-trained and 14 M.D.-trained investigators, the majority of whom have established independent research careers.
Bryan Bergman, PhD
Director, Molecular and Cellular Analytical Core
Dr. Bergman is a Professor in the Division of Endocrinology, Diabetes, and Metabolism at the University of Colorado Anschutz Medical Campus. Dr. Bergman’s research investigates the relationship between muscle lipids and insulin sensitivity, and he has been continuously funded by the NIH since 2005. His laboratory focuses on two main research themes. One theme seeks to understand the relationship between skeletal muscle subcellular lipid localization and insulin resistance in humans. Specifically, his lab is investigating how the intracellular location, molecular species, and isomers of diacylglycerol and sphingolipids promote insulin resistance in humans. The current study is investigating these changes after insulin sensitizing lifestyle interventions and is funded by R01DK111559. The second research emphasis aims to elucidate how intermuscular adipose tissue impacts skeletal muscle insulin sensitivity, muscle strength, and size in humans. This study combines muscle biopsy visits with elective surgeries to obtain intermuscular, subcutaneous, and visceral adipose tissue biopsies and is funded by R01DK118149. Dr. Bergman’s laboratory also pursues mechanistic relationships between inter- and intra-muscular lipids and insulin sensitivity using primary muscle cell culture. This model is unique as the phenotype of donor is maintained in culture. They are using this model to determine mechanisms underlying the relationship between localized muscle lipids and insulin sensitivity, and how the secretome of intermuscular adipose tissue promotes insulin resistance. The overall goal of Dr. Bergman’s research is to uncover novel therapeutic targets to increase muscle insulin sensitivity, a need not met by current therapies, to help prevent and treat pre-diabetes and type 2 diabetes.
Kartik Shankar, PhD
Associate Director, Molecular and Cellular Analytical Core
Dr. Kartik Shankar recently joined the Department of Pediatrics, Section of Nutrition. Prior to his appointment at CU Anschutz, Kartik was a Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences and Associate Director at the Arkansas Children’s Nutrition Center. Research in his laboratory is aimed at understanding how maternal obesity, diet and life-style in the peri-conceptional period influence long-term health of the offspring. Specifically, his current studies are focused on understanding the epigenomic and non-genetic transmissible factors (such as the microbiome) contributing to intergenerational transmission of obesity risk in a translational fashion. These studies leverage basic animal models in conjunction with longitudinal prospective clinical studies in mothers and infants
Janine Higgins, PhD
Director, CLINICAL INTERVENTION AND TRANSLATION CORE
Janine Higgins is a Professor of Pediatrics, Section of Endocrinology. She received her Ph.D. in biochemistry at the University of Sydney and completed post-Doctoral Fellowships at the University of Wollongong and the University of Colorado Denver. She has been the Colorado Clinical and Translational Sciences Institute (CCTSI) Nutrition Research Director for the past 15 years and CCTSI Director of Operations for four years. In 2018 alone, the CCTSI Nutrition Core dispensed 7,787 weighed research meals (6,230h of labor) plus an additional 85h of other services such as diet diary analysis, photographic food record analysis, dietary counseling, and administration of FFQs. Dr. Higgins has over 18 years’ experience in Nutrition research in rodent models, children, and adults. Her primary research interests center around diet and metabolism: investigating optimal treatment of Type 2 diabetes in children and adolescents (NIH multi-center TODAY study), development of novel methods for measurement of dietary intake, obesity treatment in adults, and ways to ameliorate weight regain following weight loss in rodent models. Dr. Higgins has extensive experience mentoring post-doctoral and clinical endocrinology, infectious disease, and gastroenterology Fellows and is a member of the selection committee and preceptor for the Children’s Hospital Colorado Academy of Nutrition and Dietetics (AND) Dietetic Internship Program. She serves as co-director of the CCTSI PreK program and an ad hoc reviewer for the K to R program.
Victoria Catenacci, MD
Associate Director, CLINICAL INTERVENTION AND TRANSLATION CORE
Dr. Catenacci is an Associate Professor of Medicine at the University of Colorado Denver School of Medicine. Her specialties include: Internal Medicine, Board Certification (2001), Internal Medicine – Endocrinology, Diabetes, and Metabolism, Board Certification (2007). She completed her Undergraduate degree with a BS from the University of Notre Dame (IN) (1994) and completed medical school from Yale University School of Medicine (1998). She further completed her internship at Yale-New Haven Medical Center Program (1999) and Residency Program: Yale-New Haven Medical Center Program, Internal Medicine (2001) Yale-New Haven Medical Center Program, Chief Resident, Internal Medicine (2002). Dr. Catenacci’s clinical interests include: Diabetes, General Endocrinology, Physical Activity and Weight Loss/Maintenance.
Edward Melanson, PhD
Director, Enrichment Program; Associate Director Energy Balance Assesement Core
Dr. Edward Melanson Ph.D., is a Professor of Medicine, Division of Endocrinology, Metabolism, and diabetes, with a secondary appointment in the Division of Geriatrics. He is also an Assistant Director of the Energy Balance Core Lab. In this capacity, he oversees the operation of the whole-room calorimeter, located on the Clinical and Translational Research Center (CTRC). Dr. Melanson’s interests are on the effects of diet, exercise, and obesity on substrate metabolism and energy expenditure. The primary areas of research in Dr. Melanson’s lab are:
Developing new methods for assessing energy expenditure and physical activity in free-living humans
Richard Johnson, MD
Dr. Johnson has performed medical research since the early 1980s and have been funded by the NIH since 1987. Most of his research has focused on the pathogenesis of kidney diseases, but during the last 12 years his studies have also included studies of the pathogenesis of primary hypertension, insulin resistance and diabetes, diabetic nephropathy, and obesity. Much of Dr. Johnson's work has involved a combination of cell culture and animal models with a strong translational component, but has also been involved in a number of clinical trials and epidemiology based studies. One of his special interests has been on the role of uric acid and of sugar (especially the component, fructose) in obesity and diabetes. As such, Dr. Johnson has greatly enjoyed his collaborations with other NORC investigators and also with the use of the NORC core facilities.
Nancy F. Krebs, MD, MS
Professor of Pediatrics, Head, Section of Nutrition, Associate Vice Chair, Academic Affairs, Dept of Pediatrics
My primary research interests in maternal and infant nutrition extend from detailed metabolic studies of zinc and iron across the life cycle, to large scale RCT of supplements and/or food-based interventions. The focus of these studies has been to define dietary micronutrient requirements and to characterize homeostasis, including metabolic regulation and adaptation to different physiologic states, in normal infants, pregnant & lactating women. I have extensive experience directing intervention trials to monitor and evaluate growth and development in infants and toddlers. Currently I direct the ongoing analyses of the preconception maternal nutrition intervention trial (“Women First”) in 4 low resource countries. Outcomes from birth through 24 months include those of public health interest (birth anthropometry, infant/child stunting rates) plus extensive maternal and infant phenotyping, e.g. metabolomics, microbiome and epigenetic data. My research laboratory extensively employs mass spectrometry (ICP-MS) to measure stable isotope tracers and multi-element mineral analyses in biological and food samples, and we conduct multiple ELISA’s for biomarkers of nutritional status.
In recent years our emphasis on studies in Denver has focused on risk factors in the first 1000 days, including effects of maternal obesity on milk production, bioactive compounds in human milk and the impact on offspring risk for excessive weight gain. We have also conducted interventions modifying the composition of complementary foods and evaluated the effects on growth, adiposity, microbiome and metabolomics. Current studies include a trial of different iron intakes in healthy formula fed newborns; outcomes include effects on the enteric microbiome, systemic and intestinal inflammation, innate immunity and metabolomics.
Kristen Boyle, PhD
My research focuses on clinical interventions combined with mechanistic investigations by using primary human cell culture models. Most recently, we have developed a model for investigating human intrauterine phenotype development using umbilical cord-derived mesenchymal stem cells (MSCs). In the context of obesity in pregnancy, these infant stem cells demonstrate greater adiposity and metabolic dysfunction consistent with the adult obesity phenotype. It is our goal to further our understanding of how maternal obesity or diabetes impact the infants born to these mothers by evaluating the epigenetic and metabolic outcomes in the infant MSCs. Moreover, longitudinal assessments of the children from which the MSCs were derived will clarify the potential role of umbilical cord MSC phenotype for predicting obesity or diabetes risk in the children.
Darleen Sandoval, PhD
My research focuses on the role of the gut-brain axis in regulation of glucose and lipid metabolism and follows along two general themes. The first focuses on the role of a gastrointestinal peptide, GLP-1, in regulation of energy and glucose homeostasis. GLP-1 is made in the gut, the pancreas, and the brain and my work seeks to understand the role of the various sources of this peptide in normal glucose regulation, how dysregulation of GLP-1 is involved with the onset of type 2 diabetes mellitus, and how increases in GLP-1 seen with bariatric surgery contribute to diabetes resolution. The second focuses on the adaptations of the gut-brain axis with bariatric surgery and how this contributes to the profound weight-loss and improvements in glucose and lipid homeostasis seen with these surgeries. I have served on numerous committees including the ADA scientific sessions organizing committee, NIH Study Section (IPOD and currently NIDDK-C), and the Endocrine Society Annual Meeting Steering Committee. I am also proud to have co-founded the Women’s Interprofessional Network of the American Diabetes Association with Dr. Jane Reusch, for which I am also currently co-chair.